These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39080486)

  • 1. A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycan.
    Gaifem J; Rodrigues CS; Petralia F; Alves I; Leite-Gomes E; Cavadas B; Dias AM; Moreira-Barbosa C; Revés J; Laird RM; Novokmet M; Štambuk J; Habazin S; Turhan B; Gümüş ZH; Ungaro R; Torres J; Lauc G; Colombel JF; Porter CK; Pinho SS
    Nat Immunol; 2024 Sep; 25(9):1692-1703. PubMed ID: 39080486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease.
    Duarte-Silva M; Afonso PC; de Souza PR; Peghini BC; Rodrigues-Júnior V; de Barros Cardoso CR
    Autoimmunity; 2019 Feb; 52(1):37-47. PubMed ID: 30884988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease.
    Müller S; Schaffer T; Schoepfer AM; Hilty A; Bodmer T; Seibold F
    World J Gastroenterol; 2008 Jun; 14(23):3650-61. PubMed ID: 18595132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
    Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M
    Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
    Kristensen VA; Cvancarova M; Høivik ML; Moum B; Vatn MH
    Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis.
    Müller S; Styner M; Seibold-Schmid B; Flogerzi B; Mähler M; Konrad A; Seibold F
    World J Gastroenterol; 2005 Nov; 11(44):6988-94. PubMed ID: 16437604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.
    Forcione DG; Rosen MJ; Kisiel JB; Sands BE
    Gut; 2004 Aug; 53(8):1117-22. PubMed ID: 15247177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens.
    Müller S; Schaffer T; Flogerzi B; Seibold-Schmid B; Schnider J; Takahashi K; Darfeuille-Michaud A; Vazeille E; Schoepfer AM; Seibold F
    Gut; 2010 Nov; 59(11):1493-500. PubMed ID: 20682699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease.
    Bertin D; Grimaud JC; Lesavre N; Benelmouloud C; Desjeux A; Garcia S; Desplat-Jégo S
    PLoS One; 2013; 8(11):e80433. PubMed ID: 24303014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.
    Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM
    Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
    Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
    Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients with reduced H-ficolin levels but normal MASP-2 activity.
    Schaffer T; Flogerzi B; Schoepfer AM; Seibold F; Müller S
    J Crohns Colitis; 2013 Feb; 7(1):e1-10. PubMed ID: 22445443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: A reappraisal of the role of S. cerevisiae in this setting.
    Sendid B; Jawhara S; Sarter H; Maboudou P; Thierny C; Gower-Rousseau C; Colombel JF; Poulain D
    Virulence; 2018; 9(1):1224-1229. PubMed ID: 30027793
    [No Abstract]   [Full Text] [Related]  

  • 15. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
    Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
    Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-food and anti-microbial IgG subclass antibodies in inflammatory bowel disease.
    Jansen A; Mandić AD; Bennek E; Frehn L; Verdier J; Tebrügge I; Lutz H; Streetz K; Trautwein C; Sellge G
    Scand J Gastroenterol; 2016 Dec; 51(12):1453-1461. PubMed ID: 27455092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn's disease from celiac disease.
    Kotze LM; Nisihara RM; Utiyama SR; Kotze PG; Theiss PM; Olandoski M
    Arq Gastroenterol; 2010; 47(3):242-5. PubMed ID: 21140083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
    Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
    Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.
    Russell RK; Ip B; Aldhous MC; MacDougall M; Drummond HE; Arnott ID; Gillett PM; McGrogan P; Weaver LT; Bisset WM; Mahdi G; Wilson DC; Satsangi J
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):161-7. PubMed ID: 19179877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.